MDCX

MKT CAP:$19M

Medicus Pharma Ltd. Common Stock

Market Cap

$19M

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NASDAQ

Healthcare·Drug Mfg.·🇺🇸·NASDAQ

Stock Price

$0.34-$1.26 (-78.89%)

Jun 12, 2026

52W High $3.4052W Low $0.28

Company Details

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell car...

Leadership

Raza Bokhari M.B.A., M.D.

CEO & Executive Chairman

Edward J. Brennan Jr., F.A.C.S., M.D.

Chief Scientific Officer and Head of R&D Program

Faisal Mehmud M.D.

Chief Medical Officer

Andrew Alasdair Smith

Chief Operating Officer

Anna Baran-Djokovic J.D.

Senior Vice President of Investor Relations

Viktoria Slepeniuk

Senior Vice President of Public Relations

Maryann Adesso

Chief of Staff & Corporate Secretary

IPO Date

Feb 3, 2016

Website

medicuspharma.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$37M

EPS (Diluted)

Free Cash Flow

-$23M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 14, 2026

FY 2025

Mar 25, 2026

Q4 2025

Mar 25, 2026

Q3 2025

Nov 14, 2025

Q2 2025

Aug 11, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee